News
Valbiotis Publishes Its 2021 Annual Report
Regulatory News:
Valbiotis (FR0013254851 – ALVAL, PEA/SME eligible), a Research and Development company committed to scientific innovation for preventing and combating metabolic diseases
Transgene to Present New Positive Preliminary Phase I Data on TG4050 (myvac® platform), its Individualized Therapeutic Cancer Vaccine, at AACR 2022
Regulatory News:
Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer will be presenting a poster with
Transgene and BioInvent Announce Poster Presentation on BT-001, a Novel Antibody-encoding Oncolytic Virus, at AACR 2022
Regulatory News:
Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, and BioInvent International AB (“BioInvent”) (Nasdaq
Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital
Regulatory News:
Nanobiotix (Paris:NANO) (NASDAQ:NBTX):
Market: Euronext Paris / Nasdaq
Euronext Compartment: B
ISIN code: FR0011341205
Nasdaq: NBTX
Bloomberg: NANO:FP
Reuters: NANO.PA
Website
Valbiotis kündigt bevorstehende organisatorische Änderungen im Vorstand an
Valbiotis (FR0013254851 – ALVAL, PEA/KMU-qualifiziert), ein Forschungs- und Entwicklungsunternehmen mit Schwerpunkt auf wissenschaftlicher Innovation zur Vorbeugung und Bekämpfung von
GAUSSIN Announces World Tour for its Hydrogen-Powered H2 Racing Truck®, Following Success at 2022 Dakar Rally
GAUSSIN (EURONEXT GROWTH ALGAU - FR0013495298), a pioneer in the clean and intelligent transport of goods and people, today announced the world tour of its H2 Racing Truck®, the world's first
Valbiotis Announces Upcoming Organizational Changes of its Board of Directors
Regulatory News:
Valbiotis (FR0013254851 – ALVAL, PEA/SME eligible) (Paris:ALVAL), a Research and Development company committed to scientific innovation for preventing and combating metabolic and
Median Technologies Files FDA 513(g) Regulatory Submission for iBiopsy® Lung Cancer Screening CADe/CADx Software as Medical Device
Regulatory News:
Median Technologies (ALMDT) announces today that the company has filed a 513(g) submission on Feb. 17, 2022 to the United States Food and Drug Administration (FDA) for its
Median Technologies to Participate in the Cowen’s 42nd Annual Health Care Conference
Regulatory News:
Median Technologies (Paris: ALMDT), will be participating in the Cowen’s 42nd Annual Health Care Conference, taking place virtually on March 7-9, 2022.
Fredrik Brag, Median’s
Führender Streaming-Dienst auf den Malediven wählt die Plattform von Verimatrix zum Schutz von App, Inhalten und Umsätzen
Verimatrix, (Euronext Paris: VMX), der führende Anbieter von menschenzentrierten Security-Lösungen zum Schutz der vernetzten Welt, meldete heute, dass ECOMXCHANGEMV Pvt Ltd sich für die Verimatrix
Leading Maldivian Streaming Service Selects Verimatrix Platform To Protect App, Content and Revenues
Regulatory News:
Verimatrix, (Euronext Paris: VMX), the leader in powering the modern connected world with people-centered security, today announced that ECOMXCHANGEMV Pvt Ltd selected the
Valbiotis veröffentlicht Finanzkommunikationskalender 2022
Regulatory News:
Valbiotis (Paris:ALVAL) (FR0013254851 - ALVAL, PEA/KMU-qualifiziert), ein Forschungs- und Entwicklungsunternehmen mit Schwerpunkt auf wissenschaftlicher Innovation zur Vorbeugung
Valbiotis Presents Its 2022 Financial Communication Calendar
Regulatory News:
Valbiotis (Paris:ALVAL) (FR0013254851 – ALVAL, PEA/SME eligible), a Research and Development company committed to scientific innovation for preventing and combating metabolic
Cadence and Dassault Systèmes Partner to Transform Electronic Systems Development
Cadence Design Systems, Inc. (Nasdaq: CDNS) and Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced a strategic partnership to provide enterprise customers in multiple vertical
Teleperformance: Record Growth in 2021: Growth in Revenue of +25.7% Like-for-like and in Net Profit Of +71.9%
Regulatory News:
The Board of Directors of Teleperformance (Paris:TEP), the global leader in outsourced customer and citizen experience management and related services, met today and reviewed the
Valbiotis gibt Genehmigung für den Start der zwei klinischen Phase-II/III-Studien INSIGHT und INSIGHT 2 bekannt - der letzte Schritt in der Entwicklung von TOTUM•854 zur Senkung von Blutdruck
Valbiotis (Paris:ALVAL) (FR0013254851 – ALVAL, PEA/SME-qualifiziert), ein französisches Forschungs- und Entwicklungsunternehmen mit Schwerpunkt auf wissenschaftlicher Innovation zur Vorbeugung und
Valbiotis Announces Approval to Launch the Two Phase II/III INSIGHT and INSIGHT 2 Clinical Studies, the Last Step in the Development of TOTUM•854 For the Reduction of Blood Pressure
Regulatory News:
Valbiotis (Paris:ALVAL) (FR0013254851 – ALVAL, PEA / SME eligible), a Research and Development company committed to scientific innovation for preventing and combating metabolic
New Milestones for NHOA in the US With Kearsarge Energy: 10MWh Storage System Successfully Commissioned and 12MWh of New Contracts Awarded
Regulatory News:
NHOA (NHOA:PA, formerly Engie EPS) is pleased to announce the successful commissioning of a new storage system in the US.
The project, awarded in December 2020, involved the
Eutelsat Communications: First Half 2021-22 Results
Regulatory News:
The Board of Directors of Eutelsat Communications (ISIN: FR0010221234 / Euronext Paris: ETL), chaired by Dominique D’Hinnin, reviewed the financial results for the Half Year
Poxel Announces PXL065 Granted FDA Fast Track Designation for X-linked Adrenoleukodystrophy
POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for serious chronic diseases with metabolic pathophysiology, including
Poxel Reports Financial Update for Cash and Revenue for the Full Year 2021 and Provides Corporate Update
POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including
Verimatrix bringt Secure Delivery Plattform an den Start, die Einnahmensicherung, Flexibilität und Mehrwert für die Sicherung von Inhalten, Anwendungen und Geräten bietet
Verimatrix, (Euronext Paris: VMX), (Paris: VMX), der führende Anbieter von benutzerorientierten Sicherheitslösungen für die moderne vernetzte Welt, meldete heute die Markteinführung der Verimatrix
Verimatrix Launches Secure Delivery Platform to Provide Revenue Protection, Agility and Additive Value for Securing Content, Applications and Devices
Verimatrix, (Euronext Paris: VMX) (Paris:VMX), the leader in powering the modern connected world with people-centered security, today announced the launch of the Verimatrix Secure Delivery Platform
Linedata Services: Growth in full-year results EBITDA up 8.9% NET PROFIT up 39.7%
Eutelsat and Marlink extend Global Maritime Partnership for GEO Ku-band satellite capacity
Regulatory News:
Eutelsat Communications (Paris:ETL) (Euronext Paris: ETL) and Marlink, the Smart Network Company, have agreed to extend their Global Maritime Partnership, initially signed in